As of 2025-05-25, the Fair Value of Molecular Pharmacology (USA) Ltd (MLPH) is -0.02 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of Molecular Pharmacology (USA) Ltd is -15,200.79%.
With the market price of 0.00 USD and our fair value calculation, Molecular Pharmacology (USA) Ltd (MLPH) is not a good investment. Investing in MLPH stocks now will result in a potential loss of 15,200.79%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2012-06-30 | 2013-06-30 | 2014-06-30 | 2015-06-30 | 2016-06-30 | 5Y Avg | |
| Net income | -0.18 | -0.21 | -0.12 | - | - | -0.13 |
| YoY growth | -47.20% | -17.01% | 44.29% | 100.00% | -% | 20.02% |
| Market Cap (mil) | 0.01 |
| P/E | |
| Forward P/E |
| EPS | -0.00 |
| Avg earnings growth rate | 20.02% |
| TTM earnings | -0.11 |